Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter - Basal transcription is mediated by Sp1 and Sp3

Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter - Basal transcription is mediated by Sp1 and Sp3
复制标题

DOI:
10.1074/jbc.m101814200
复制
发表时间:
2001-09-07
影响因子:
4.8
通讯作者:
Eling, TE
Eling, TE
中科院分区:
生物学2区
文献类型:
--
作者:
Baek, SJ;Horowitz, JM;Eling, TE

文献摘要

被引文献

相似文献

非甾体抗炎药激活基因(NAG-1)是已知的与抗肿瘤活性,属于转化生长因子β超家族。在本研究中,我们克隆了启动子区(-3500至+41),并研究了人NAG-1基因基础表达的转录调控机制。几个潜在的转录因子结合位点在这个区域被确定。基于来自巢式缺失的克隆的结果,在-133和+41碱基对之间的构建体包含三个Sp1结合位点(Sp1-A、Sp1-B和Sp1-C),其赋予NAG-1表达的基础转录特异性活性。当Spi-C位点突变(GG至TT)时,在HCT-116细胞中观察到启动子活性降低60-80%。凝胶位移,共转染,染色质免疫沉淀试验表明,SP转录因子结合到Spl-binding网站和反式激活NAG-1的表达。此外,鸡卵清蛋白上游启动子转录因子I可以与Sp1和Sp3蛋白的C-末端区域相互作用,并通过SpI和Sp3转录因子诱导NAG-1启动子活性。这些结果确定了人NAG-1基础启动子的关键调控区域。此外,结果表明,NAG-1基因的表达水平将取决于Sp蛋白的可用性和辅因子,如鸡卵清蛋白上游启动子转录因子1。
Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is known to be associated with anti-tumorigenic activity and belongs to the transforming growth factor-beta superfamily. In the present study, we cloned the promoter region (-3500 to +41) and investigated the transcriptional regulatory mechanisms of the basal expression of the human NAG-1 gene. Several potential transcription factor-binding sites in this region were identified. Based on the results from clones of nested deletions, the construct between -133 and +41 base pairs contains three Sp1-binding sites (Sp1-A, Sp1-B, and Sp1-C, which confer basal transcription specific activity of NAG-1 expression. When the Spi-C site was mutated (GG to TT), a 60-80% decrease in promoter activity was observed in HCT-116 cells. Gel shift, cotransfection, and chromatin immunoprecipitation assays showed that the Sp transcription factors bind to the Spl-binding sites and transactivate NAG-1 expression. In addition, chicken ovalbumin upstream promoter transcription factor I can interact with the C-terminal region of Sp1 and Sp3 proteins and induce NAG-1 promoter activity through SpI and Sp3 transcription factors. These results identify the critical regulatory regions for the human NAG-1 basal promoter. Furthermore, the results suggest that the level of expression of the NAG-1 gene will depend on the availability of Sp proteins and on co-factors such as chicken ovalbumin upstream promoter-transcription factor 1.